Skip to main content

Advertisement

Table 5 Incidence of TEAEs Associated With Discontinuation

From: Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder

  Placebo
(n = 62)
30 mg/d LDX
(n = 119)
50 mg/d LDX
(n = 117)
70 mg/d LDX
(n = 122)
Active Doses
(n = 358)
Discontinuation, n (%)      
   Insomnia 0 (0) 2 (1.7) 3 (2.6) 3 (2.5) 8 (2.2)
   Sleep disorder 0 (0) 0 (0) 1 (0.9) 0 (0) 1 (0.3)
   Hypersomnia 0 (0) 1 (0.8) 0 (0) 0 (0) 1 (0.3)